Success and failure are dynamic, recurrent event states after surgical treatment for pelvic organ prolapse.
J Eric Jelovsek, Marie G Gantz, Emily Lukacz...
https://pubmed.ncbi.nlm.nih.gov/33039390/Actively Recruiting
Led by Charles University, Czech Republic · Updated on 2026-03-19
592
Participants Needed
8
Research Sites
260 weeks
Total Duration
Pelvic organ prolapse POP, especially defects in the anterior compartment, significantly affects the quality of life in women. This trial focuses on comparing two surgical methods to repair cystocele, a common type of POP caused mainly by paravaginal defects in vaginal support. The study aims to evaluate the safety and effectiveness of a new minimally invasive surgery called transobturator cystocele repair TOCR against the standard anterior colporrhaphy AR to improve cystocele repair outcomes over one year. Participants will receive either the novel TOCR procedure or the standard AR surgery. TOCR involves a transvaginal approach using continuous non-locking stitches through the obturator membrane and muscle with non-absorbable sutures, followed by closure of the vaginal skin. The AR technique uses a midline vaginal incision to dissect and repair the pubocervical fascia with interrupted sutures and trims excess vaginal tissue. Both groups receive indometacin rectal suppositories for early postoperative pain management. Women in the trial will undergo assessments before and after surgery, including anatomical evaluations of prolapse repair success at 1 and 2 years, complication monitoring, pain assessment 14 days post-surgery, and questionnaires on subjective improvement and quality of life related to urinary and pelvic symptoms. The study includes follow-up visits to measure patient satisfaction and monitor new urinary symptoms. The total follow-up period extends up to two years to observe long-term outcomes and safety.
CONDITIONS
Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS
V
Vladimir Kalis, prof. MD PhD
Z
Zdenek Rusavy, assoc. prof. MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Charles University, Czech Republic
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgical procedure plus immediate recovery period
Participants undergo one of two surgical procedures to repair pelvic organ prolapse: the novel transobturator cystocele repair or the standard anterior colporrhaphy. Early post-operative pain management is provided.
1 surgery visit and immediate post-operative care
Duration - Up to 1 year
Participants are monitored for safety, efficacy, and quality-of-life improvements following surgery, including assessments of anatomic and composite surgery failure, complications, pain, and patient satisfaction.
Multiple follow-up visits during the year after surgery
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
J Eric Jelovsek, Marie G Gantz, Emily Lukacz...
https://pubmed.ncbi.nlm.nih.gov/33039390/Michal Otcenasek, Annett Gauruder-Burmester, Lucia A Haak...
https://pubmed.ncbi.nlm.nih.gov/26800142/Ea Løwenstein, Bent Ottesen, Helga Gimbel
https://pubmed.ncbi.nlm.nih.gov/24842118/K S Leffler, J R Thompson, G W Cundiff...
https://pubmed.ncbi.nlm.nih.gov/11483901/Orawee Chinthakanan, John R Miklos, Robert D Moore
https://pubmed.ncbi.nlm.nih.gov/26680393/Renaud de Tayrac, Laurent Boileau, Jean-François Fara...
https://pubmed.ncbi.nlm.nih.gov/19924370/Charlotte Delacroix, Lucie Allegre, Kyriaki Chatziioannidou...
https://pubmed.ncbi.nlm.nih.gov/35226145/Vladimir Kalis, Veronika Kovarova, Zdenek Rusavy...
https://pubmed.ncbi.nlm.nih.gov/32494957/Renée M Ward, Vivian W Sung, Jeffrey L Clemons...
https://pubmed.ncbi.nlm.nih.gov/18060976/Louise T S Arenholt, Bodil Ginnerup Pedersen, Karin Glavind...
https://pubmed.ncbi.nlm.nih.gov/30506182/Charles University, Czech Republic
Lead Sponsor